2017
DOI: 10.1093/europace/eux163
|View full text |Cite|
|
Sign up to set email alerts
|

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Abstract: This categorization for our consensus document should not be considered as being directly similar to that used for official society guideline recommendations which apply a classification (I-III) and level of evidence (A, B, and C) to recommendations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
96
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 194 publications
(101 citation statements)
references
References 114 publications
3
96
0
1
Order By: Relevance
“…We definitely agree with the authors' statement that routine use of implantable loop recorders in patients with cryptogenic stroke should be based on randomized prospective studies and is not yet unrestrictedly recommended in the cited recent consensus document [1]. However, we are convinced that the observational data currently available is promising and may even allow prediction of atrial fibrillation before it is detected.…”
Section: Sirssupporting
confidence: 61%
“…We definitely agree with the authors' statement that routine use of implantable loop recorders in patients with cryptogenic stroke should be based on randomized prospective studies and is not yet unrestrictedly recommended in the cited recent consensus document [1]. However, we are convinced that the observational data currently available is promising and may even allow prediction of atrial fibrillation before it is detected.…”
Section: Sirssupporting
confidence: 61%
“…Studies have demonstrated that device-detected episodes of AF ranging in duration from 5 min to 24 h are associated with increased risk of stroke, with the clearest evidence for an increased risk for episodes of 24 h or more. 19 A recent consensus document has recommended initiation of OAC in appropriate device patients with >5.5 h of daily AF burden, 20 while others have suggested shorter and longer AF durations dependent on a patient's underlying risk for stroke. 21 Regardless of the actual cut-off used, our data demonstrate that AT/AF is common and steadily increases over time.…”
Section: Discussionmentioning
confidence: 99%
“…11 Several episodes of high atrial rate were detected by the ICM, which can be used for detection of AF. 12 Despite limited evidence of the benefit of anticoagulation based on device-detected AF, 13 especially shorter episodes, given the guidelines that for HCM advocate munificent treatment, we justified dabigatran in this patient who already had suffered from a stroke.…”
Section: Atrial Fibrillation and Risk Of Strokementioning
confidence: 99%